575 related articles for article (PubMed ID: 19466980)
1. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
Gernsheimer T
Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
[TBL] [Abstract][Full Text] [Related]
4. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
5. [Dysmegakaryocytopoiesis and thrombopoiesis in autoimmune thrombocytopenias].
Bellucci S
C R Seances Soc Biol Fil; 1996; 190(5-6):541-8. PubMed ID: 9074719
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
8. The effect of antiplatelet autoantibodies on megakaryocytopoiesis.
McMillan R; Nugent D
Int J Hematol; 2005 Feb; 81(2):94-9. PubMed ID: 15765775
[TBL] [Abstract][Full Text] [Related]
9. Other immune thrombocytopenias.
Liebman H
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in understanding the pathogenesis of immune thrombocytopenia.
Semple JW; Provan D; Garvey MB; Freedman J
Curr Opin Hematol; 2010 Nov; 17(6):590-5. PubMed ID: 20739879
[TBL] [Abstract][Full Text] [Related]
11. Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE).
Fabris F; Scandellari R; Randi ML; Carraro G; Luzzatto G; Girolami A
Haematologica; 2002 Oct; 87(10):1046-52. PubMed ID: 12368159
[TBL] [Abstract][Full Text] [Related]
12. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
13. Immune thrombocytopenia: pathophysiologic and clinical update.
Stasi R
Semin Thromb Hemost; 2012 Jul; 38(5):454-62. PubMed ID: 22753097
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
15. Platelet IgG: measurement, interpretation, and clinical significance.
George JN
Prog Hemost Thromb; 1991; 10():97-126. PubMed ID: 2008535
[TBL] [Abstract][Full Text] [Related]
16. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study.
Bruin M; Bierings M; Uiterwaal C; Révész T; Bode L; Wiesman ME; Kuijpers T; Tamminga R; de Haas M
Br J Haematol; 2004 Dec; 127(5):561-7. PubMed ID: 15566359
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
Kuwana M; Kaburaki J; Ikeda Y
J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
[TBL] [Abstract][Full Text] [Related]
18. Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction.
Tomer A; Hanson SR; Harker LA
J Lab Clin Med; 1991 Dec; 118(6):546-54. PubMed ID: 1744503
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and thrombokinetics in autoimmune thrombocytopenia.
Gernsheimer T
Blood Rev; 2002 Mar; 16(1):7-8. PubMed ID: 11913984
[TBL] [Abstract][Full Text] [Related]
20. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
